GHRP-2 2 MG

GHRP-2 2 mg – Peptide Hubs

GHRP-2 (Growth Hormone Releasing Peptide-2) is a potent synthetic hexapeptide widely used in research for stimulating natural growth hormone (GH) secretion via the ghrelin receptor. It is one of the most studied peptides in the GHRP family and offers excellent potential in body composition, recovery, and anti-aging studies. Peptide Hubs offers a high-purity 2 mg lyophilized vial optimized for accurate and consistent experimental use.

What Is GHRP-2?

GHRP-2 binds to the ghrelin receptor (GHS-R1a), leading to a rapid increase in endogenous GH release. It is stronger than GHRP-6 in terms of GH spike but causes less appetite stimulation. Unlike GHRH analogs, GHRP-2 acts directly on the pituitary and hypothalamus to promote pulsatile GH secretion. Researchers also observe secondary benefits such as IGF-1 elevation, improved sleep quality, and appetite modulation. For background, read this NIH review on GHRPs and ghrelin receptor agonists.

Research Applications

GHRP-2 is widely used in studies related to:

• Growth hormone stimulation and GH deficiency models
• Muscle mass retention and anabolic recovery
• Appetite regulation and metabolic balance
• Sleep quality and circadian rhythm improvement

GHRP-2 is often evaluated alongside GHK Basic 50 mg for regenerative support or stacked with AOD 9604 for fat metabolism studies. In GH-optimization cycles, it may also be combined with CJC-1295 DAC for synergistic growth hormone pulse amplification.

Suggested Experimental Use

• Dosage Range: 100–300 mcg per dose, 1–3 times daily
• Administration: Subcutaneous injection (fasted state preferred)
• Cycle: 4–12 weeks depending on study design

Stacking Combinations

Researchers often stack GHRP-2 with complementary peptides depending on the research goal:

• DSIP – for sleep enhancement and cortisol modulation
• FOX04-DRI – to study aging pathways in relation to GH secretion
• B7-33 – to reduce fibrosis and support tissue elasticity
• Cardiogen – for cardiovascular tissue regeneration studies

Safety & Legality

GHRP-2 is for laboratory research only and is not approved for human use. Potential side effects observed in animal and preclinical models may include increased prolactin or cortisol at very high doses. No aromatization, liver toxicity, or estrogenic effects have been observed. For ongoing research into ghrelin mimetics, see ClinicalTrials.gov.

Frequently Asked Questions